Editorial: Current Status of Two Adjuvanted Malaria Vaccines and the World Health Organization (WHO) Strategy to Eradicate Malaria by 2030

There is hope that 2023 could bring regulatory approval, licensing, and implementation programs for safe and effective adjuvanted vaccines to prevent malaria. Clinical trials involving the two leading adjuvanted malaria vaccines directed to the Plasmodium falciparum circumsporozoite protein (PfCSP)...

Descripción completa

Detalles Bibliográficos
Autor principal: Parums, Dinah V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2023
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814194/
https://www.ncbi.nlm.nih.gov/pubmed/36587274
http://dx.doi.org/10.12659/MSM.939357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814194/
https://www.ncbi.nlm.nih.gov/pubmed/36587274
http://dx.doi.org/10.12659/MSM.939357

Ejemplares similares